Member access

4-Traders Homepage  >  Shares  >  Tokyo  >  ONO PHARMACEUTICAL CO., LTD.    4528   JP3197600004

 SummaryChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Company
Ono Pharmaceutical Co., Ltd. engages in the production, purchase, and sale of pharmaceutical and diagnostic reagents focusing on prescription pharmaceuticals.Its products include respiratory, digestive, urinary, chemotherapy, hormone, vitamins, and metabolic drugs.The company was founded by Ichibei... 
Sector
Pharmaceuticals
Calendar
11/05Earnings Release
Surperformance© rating of ONO PHARMACEUTICAL CO., LT
Trading Rating : Investor Rating :
More about the company
Chart ONO PHARMACEUTICAL CO., LT
Duration : Period :
ONO PHARMACEUTICAL CO., LT Technical Analysis Chart | 4528 | JP3197600004 | 4-Traders
Full-screen chart
Financials ( JPY)
Sales 2015 136 622 M
EBIT 2015 13 250 M
Net income 2015 14 301 M
Finance 2015 123 998 M
Yield 2015 1,72%
Sales 2016 149 120 M
EBIT 2016 -
Net income 2016 17 639 M
Finance 2016 115 229 M
Yield 2016 1,72%
PER 2015 79,47
PER 2016 64,38
EV / Sales 2015 8,11x
EV / Sales 2016 7,49x
Capitalization 1 231 506 M
More Financials
Latest news on ONO PHARMACEUTICAL CO., LT
1d ago Establishment of GPCR Consortium, a New International Partnership, to Advance..
2d ago ONO PHARMACEUTICAL : Establishment of GPCR Consortium, a New International Partn..
10/02 ONO PHARMACEUTICAL : Bristol-Myers Squibb Announces Multiple Regulatory Mileston..
09/29 ONO PHARMACEUTICAL : Positive Phase 3 Data for Opdivo (nivolumab) in Advanced Me..
09/29 ONO PHARMACEUTICAL : Helsinn Group, Switzerland, announced the results of Phase ..
09/26 ONO PHARMACEUTICAL CO., LTD. : ex-dividend day for interim dividend
09/01 ONO PHARMACEUTICAL : Human Anti-human PD-1 Monoclonal Antibody OPDIVO® Intraveno..
08/20 ONO PHARMACEUTICAL : Announcement of top-line results from Phase 3 FOCUS Trial o..
07/28 ONO PHARMACEUTICAL : and Meiji Seika Pharma enter into an agreement on developme..
07/24 ONO PHARMACEUTICAL : and Bristol-Myers Squibb Announce Strategic Immuno-Oncology..
07/10 ONO PHARMACEUTICAL : Human Anti-human PD-1 Monoclonal Antibody OPDIVO® Bristol-M..
07/09 ONO PHARMACEUTICAL : "Left Ventricular Diastolic Function Improving Agent" in Pa..
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF